Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Aclaris reports topline phase IIa data on ATI-1777 in moderate to severe atopic dermatitis

June 9, 2021

Dermira synthesizes new MRGPRX2 antagonists

June 4, 2021

NFlection presents positive phase IIa data for NFX-179 gel

May 27, 2021

Connect begins phase I trial of CBP-174 for chronic inflammatory pruritus

May 26, 2021

Sonelokimab shows significant clinical benefit over placebo in patients with plaque psoriasis

May 26, 2021

Incyte initiates phase II study of INCB-054707 in nonsegmental vitiligo

May 21, 2021

First patients dosed in phase I study of PBI-100

May 21, 2021

Olix initiates phase II study of OLX-10010 as treatment of hypertrophic scars

May 21, 2021

China's NMPA approves phase I trial of InnoCare's TYK2 inhibitor ICP-332

May 19, 2021

Phase III trials of ruxolitinib in vitiligo meet endpoints

May 17, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026